Search Results - "Bonnefont, J P"

Refine Results
  1. 1

    mtDNA mutations variously impact mtDNA maintenance throughout the human embryofetal development by Steffann, J., Monnot, S., Bonnefont, J.-P.

    Published in Clinical genetics (01-11-2015)
    “…Mitochondria are the largest generator of ATP in the cell. It is therefore expected that energy‐requiring processes such as oocyte maturation, early embryonic…”
    Get full text
    Journal Article
  2. 2

    Long-Term Follow-Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency by Bonnefont, J P, Bastin, J, Laforêt, P, Aubey, F, Mogenet, A, Romano, S, Ricquier, D, Gobin‐Limballe, S, Vassault, A, Behin, A, Eymard, B, Bresson, J L, Djouadi, F

    Published in Clinical pharmacology and therapeutics (01-07-2010)
    “…Carnitine palmitoyltransferase 2 (CPT2) deficiency is a rare mitochondrial fatty acid oxidation (FAO) disorder characterized by myalgia, exercise intolerance,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis by Steffann, J, Frydman, N, Gigarel, N, Burlet, P, Ray, P F, Fanchin, R, Feyereisen, E, Kerbrat, V, Tachdjian, G, Bonnefont, J-P, Frydman, R, Munnich, A

    Published in Journal of medical genetics (01-03-2006)
    “…Background: Diseases arising from mitochondrial DNA (mtDNA) mutations are usually serious pleiotropic disorders with maternal inheritance. Owing to the high…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Increased incidence of obstetric complications in women carrying mitochondrial DNA mutations: a retrospective cohort study in a single tertiary centre by Kuleva, M, Ben Miled, S, Steffann, J, Bonnefont, JP, Rondeau, S, Ville, Y, Munnich, A, Salomon, LJ

    “…Objective To investigate the obstetric outcome of women carriers of the oxidative phosphorylation (OXPHOS) disorder mutation. Design A retrospective cohort…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Multiple displacement amplification improves PGD for fragile X syndrome by Burlet, P., Frydman, N., Gigarel, N., Kerbrat, V., Tachdjian, G., Feyereisen, E., Bonnefont, J.-P., Frydman, R., Munnich, A., Steffann, J.

    Published in Molecular human reproduction (01-10-2006)
    “…We report an improvement in the PGD test for fragile X syndrome (FXS). Recently, multiple displacement amplification (MDA) has been reported to yield large…”
    Get full text
    Journal Article
  10. 10

    Monozygotic twins discordant for submicroscopic chromosomal anomalies in 2p25.3 region detected by array CGH by Rio, M, Royer, G, Gobin, S, de Blois, MC, Ozilou, C, Bernheim, A, Nizon, M, Munnich, A, Bonnefont, J-P, Romana, S, Vekemans, M, Turleau, C, Malan, V

    Published in Clinical genetics (01-07-2013)
    “…Although discordant phenotypes in monozygotic twins with developmental disorder are not an exception, underlying genetic discordance is rarely reported. Here,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Stability of the m.8993T→G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome by Steffann, J, Gigarel, N, Corcos, J, Bonnière, M, Encha-Razavi, F, Sinico, M, Prevot, S, Dumez, Y, Yamgnane, A, Frydman, R, Munnich, A, Bonnefont, J P

    Published in Journal of medical genetics (01-10-2007)
    “…Background: Mitochondrial DNA (mtDNA) mutations cause a wide range of serious genetic diseases with maternal inheritance. Because of the high transmission risk…”
    Get full text
    Journal Article
  13. 13

    Recognition and management of fatty acid oxidation defects : A series of 107 patients by SAUDUBRAY, J. M, MARTIN, D, BONNEFONT, J. P, RABIER, D, KAMOUN, P, BRIVET, M, DE LONLAY, P, TOUATI, G, POGGI-TRAVERT, F, BONNET, D, JOUVET, P, BOUTRON, M, SLAMA, A, VIANEY-SABAN, C

    Published in Journal of inherited metabolic disease (01-06-1999)
    “…In a personal series of 107 patients, we describe clinical presentations, methods of recognition and therapeutic management of inherited fatty acid oxidation…”
    Get full text
    Conference Proceeding Journal Article
  14. 14

    Post-mortem MRI reveals CPT2 deficiency after sudden infant death by Bouchireb, Karim, Teychene, Anne-Marie, Rigal, Odile, de Lonlay, Pascale, Valayannopoulos, Vassili, Gaudelus, Joel, Sellier, Nicolas, Bonnefont, J. P., Brivet, Michèle, de Pontual, Loic

    Published in European journal of pediatrics (01-12-2010)
    “…Inherited metabolic disorders are the cause of a small but significant number of sudden infant deaths in infants. We report on a boy who suddenly died at…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Prenatal diagnosis and normal outcome of a 46,XX/46,XY chimera: A Case Report by Malan, Valérie, Gesny, R., Morichon-Delvallez, N., Aubry, M.C., Benachi, A., Sanlaville, D., Turleau, C., Bonnefont, J.P., Fekete-Nihoul, C., Vekemans, M.

    Published in Human reproduction (Oxford) (01-04-2007)
    “…The phenotypic spectrum of 46,XX/46,XY chimeric patients is variable. It ranges from normal male or female genitalia to different degrees of ambiguous…”
    Get full text
    Journal Article
  17. 17

    Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells by Béroud, C, Karliova, M, Bonnefont, JP, Benachi, A, Munnich, A, Dumez, Y, Lacour, B, Paterlini-Bréchot, P

    Published in The Lancet (British edition) (22-03-2003)
    “…Spinal muscular atrophy (SMA) has a prevalence of one in 6000 births and a one in 40 heterozygote frequency. We aimed to develop a routine test for…”
    Get full text
    Journal Article
  18. 18

    Clinical presentation of mitochondrial disorders in childhood by Munnich, A., Rötig, A., Chretien, D., Cormier, V., Bourgeron, T., Bonnefont, J. ‐P., Saudubray, J. ‐M., Rustin, P.

    Published in Journal of inherited metabolic disease (01-01-1996)
    “…Summary Respiratory‐chain deficiencies have long been regarded as neuromuscular diseases. In fact, oxidative phosphorylation, i.e. adenosine triphosphate (ATP)…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Pearson's marrow-pancreas syndrome : a multisystem mitochondrial disorder in infancy by RÖTIG, A, CORMIER, V, MUNNICH, A, BLANCHE, S, BONNEFONT, J.-P, LEDEIST, F, ROMERO, N, SCHMITZ, J, RUSTIN, P, FISCHER, A, SAUDUBRAY, J.-M

    Published in The Journal of clinical investigation (01-11-1990)
    “…Pearson's marrow-pancreas syndrome (McKusick No. 26056) is a fatal disorder of hitherto unknown etiology involving the hematopoietic system, exocrine pancreas,…”
    Get full text
    Journal Article
  20. 20